Comment on: Efficacy and safety of enteral recombinant human insulin for reduction of time-to-full enteral feeding in preterm infants: a randomized, double-blind, placebo-controlled trial (IMAJ September 2021)

Isr Med Assoc J. 2021 Nov;23(11):751.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Double-Blind Method
  • Enteral Nutrition*
  • Humans
  • Infant
  • Infant, Newborn
  • Infant, Premature
  • Insulins*
  • Weight Gain

Substances

  • Insulins